Atlas Trials

Anti-SARS Cov-2 T Cell Infusions for COVID 19

Clinical trial NCT04401410 · TERMINATED

Trial details

NCT number
NCT04401410
Sponsor
Baylor College of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV 2Viral InfectionCOVID 19
Start date
2020-11-04
Primary completion
2021-10-12
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.